Diagnos Inc.

Diagnos Inc.

December 01, 2010 13:48 ET

DIAGNOS and Its Exclusive Partner, Canamexport, Announces the Signature of a Letter of Intent from Latin American Optical and Ophthalmic Chain

BROSSARD, QUEBEC--(Marketwire - Dec. 1, 2010) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge-extraction techniques, announced today that it has received a Letter of Intent to commence commercial implementation of CARA from OFTALMOLASER DE MEXICO S.A. DE C.V., (Oftalmolaser), the medical subsidiary of GRUPO DEVLYN, S.A. De C.V., (Devlyn). Devlyn is the largest optical chain in Latin America with over 700 optical outlets and 7 ophthalmic clinics.

The letter of intent culminates a period of clinical evaluation subsequent to a MoU signed earlier this year, and announced on February 4th 2010. "We have worked closely with Oftalmolaser and Grupo Devlyn in 2010 and we are very pleased to have been selected as their diabetic retinopathy screening service provider" said Peter Nowacki, DIAGNOS' Vice-President - Healthcare.

The letter of intent states that Oftalmolaser intends to enter into a formal contract with DIAGNOS in December 2010, order initial cameras before the end of the year, and launch initial CARA-supported diabetic retinopathy screening within their network of 700 optical outlets in January 2011. A number of up to 30 screening locations are planned in 2011.

"Given our commitment as a family and as a business to the health of our communities, we plan to use DIAGNOS' technology to support our screening for eye diseases at our chain of optical stores, to increase the rate and quality of referrals for treatment in our medical clinics, and ultimately to make a difference in the vision care of 15 million Mexicans with diabetes, 50% of whom are undiagnosed. We are looking forward to working with DIAGNOS and their CARA diabetic retinopathy screening software" said Andrew Devlyn, Grupo Devlyn's Medical Division Director.

About Oftalmolaser

Oftalmolaser is a subsidiary of Grupo Devlyn and is a major provider of ophthalmic medical services, including surgical, services to its clients. Oftalmolaser currently operates 7 medical clinics in Mexico, and is growing its business throughout the region.

About Devlyn

Founded in 1963, Grupo Devlyn is private company that operates a retail chain of over 700 optical stores in Mexico, Central America and California, and is the largest optical chain in Latin America.


Founded in 1998, DIAGNOS is a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including natural resources, healthcare, and entertainment.

For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release.

Contact Information